Meet our Team
Jonathan Cohen
President & CEO
Jonathan Cohen is the founder, president, and CEO of 20/20 GeneSystems. Under Mr. Cohen’s leadership, 20/20 has brought in approximately $7.5 million in grant funding and launched two successful products, a bio-detection kit for suspicious powders used by hundreds of emergency responder organizations worldwide and a blood test for the early detection of lung cancer. He is the co-inventor of an AI approach for improving tumor biomarker accuracy that is covered in a pending PCT International Patent Application.
Michael Leibowitz, PHD
CHIEF SCIENTIFIC OFFICER
Jiming Zhou, Ph.D.
CHIEF OPERATING OFFICER
ZHOU GRADUATED FROM SICHUAN UNIVERSITY (CHINA) AND SERVED AS AN ASSOCIATE PROFESSOR BEFORE MOVING TO THE US, CONDUCTING 7 YEARS ACADEMIC RESEARCH AT UNIVERSITY OF IOWA. DR. ZHOU PUBLISHED 30+ PEER-REVIEWED RESARCH PAPER, AWARDED MULTIPLE GRANTS AND PATENTS.
IN 2005, DR. ZHOU THEN JOINED INDUSTRIAL R&D, LED A JOINT PHARMACEUTICAL PROJECT TOTAL MILESTONES OF $330 MILLION. FROM 2009, DR. ZHOU MANAGED MULTIPLE CLINICAL LABS AND CO-FUNDED 2 COMPANIES, WORKED WITH MANY LARGE US AND CHINESE PUBLIC AND PRIVATE HEALTHCARE INSTITUTES IN MULTIPLE PROJECTS.
Barry Cohen
Information Systems & Portals
Ron Baker
Sales Director
Joe Szematowicz
Marc Gordon
CoNtroller
Robyn Cohen
Office Manager
Eitan Charnoff
Sales and Marketing Specialist – Emergency Responders & International Business Development
Thierry Camara
Manufacturing
Arielle Welch
Lab Technician
Jennifer Xu
Lab Technician
David Schodin
Legal & Business Development
Richard Scherer
Laboratory Operations Technician
Olivia Price
Lab Technician
Jennifer Xu
Lab Technician
Peichang Shi
Machine Learning
Shayan Littman
Sales
Juliana Woodcock 'Julie’
Laboratory Operations
Board Members
Michael Ross, M.D.
John G. Compton, Ph. D.
He Shen
Richard Cohen, CPA
